Managing buffers in bioprocessing remains a largely manual process, requiring space and resources and often creating bottlenecks that increase costs and decrease efficiency. Researchers from many of ...

The strategic partnership will establish a joint solution for the efficient creation of buffers created from concentrates delivered directly to manufacturing facilities, increasing productivity and ...

Nucleus Biologics launched the Krakatoa ® K500, which the company says is the first bioreactor-scale, pod-based media and buffer manufacturing system designed to deliver sterile solutions on demand ...

BILLERICA, Mass.--(BUSINESS WIRE)--Nirrin Technologies, a developer of analytical tools poised to transform bioprocess analysis, today announced a joint partnership with Boston BioProducts, a cGMP ...

Discover valuable insights for transforming your biopharmaceutical production with our comprehensive resource. We take a deep dive into the latest industry trend of outsourcing buffer and process ...

Produces 35–500 liters of sterile media and buffers on demand at point-of-use, reducing cost, complexity, and lead times Pod-based, closed single-use system with integrated analytics, QR-code-driven ...

Production systems increasingly rely on sophisticated strategies for buffer allocation and optimisation to improve throughput and reduce operating costs. In modern manufacturing, buffers serve as ...

Helping pharmaceutical companies increase production efficiency and manage risk more effectively MOTIV is a buffer management technology for the vast majority of processes in pharmaceutical ...

The MarketWatch News Department was not involved in the creation of this content. -- Produces 35--500 liters of sterile media and buffers on demand at point-of-use, reducing cost, complexity, and lead ...